(No ratings)
Dr. Igor Matushansky, MD PHD is a medical oncologist in New York, NY specializing in medical oncology and physician. He graduated from Albert Einstein College of Medicine of Yeshiva University in 2001 and has 25 years of experience. Dr. Igor Matushansky, MD PHD is affiliated with NewYork-Presbyterian, ColumbiaDoctors, CUIMC/Herbert Irving Pavilion and TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK.
Dr. Igor Matushansky, MD PHD graduated from Albert Einstein College of Medicine of Yeshiva University in 2001. He completed residency at New York-Presbyterian Hospital. He is certified by the Board Certification: medical oncology and has a state license in New York.
Medical School: Albert Einstein College of Medicine of Yeshiva University (2001)
Residency: New York-Presbyterian Hospital
Board Certification: Board Certification: medical oncology
Licensed In: New York
Dr. Igor Matushansky, MD PHD appears to accept the following insurance providers: VNSNY CHOICE, CIGNA, Healthspring (Cigna Medicare), Local 1199, Empire Blue Cross/Blue Shield, Emblem/GHI, ElderServe, Medicare, Affinity Health Plan, Amida Care, UnitedHealthcare, Empire Blue Cross Blue Shield Healthplus, Emblem/Hip, Fidelis Care, MVP Health Care, WellCare, World Trade Center Health Plan, Magnacare (National), AETNA, Multiplan, Healthfirst, MultiPlan, United Healthcare PPO, United Healthcare POS, United Healthcare HMO, Aetna POS, MVP Health Care, MagnaCare, Vytra, Great-West Healthcare, Healthfirst, Aetna EPO, Aetna PPO, Aetna HMO, GHI PPO, Group Health Incorporated (GHI), Aetna Signature Administrators, CIGNA PPO, CIGNA POS, CIGNA HMO, CIGNA EPO, EmblemHealth, WellCare, Medicaid Managed Care, Blue Shield PPO, Blue Shield HMO, Blue Shield EPO, HealthSpring, UnitedHealthcare, Affinity Health Plan, United Healthcare, Medicare, Medicaid, Railroad Medicare, Cigna, 1199SEIU, Oxford HMO, Fidelis Care, HIP PPO, HIP POS, HIP EPO, HIP HMO, Empire BlueCross BlueShield HMO, Empire BlueCross BlueShield PPO, Empire BlueCross BlueShield, Aetna, Healthfirst - Leaf (Exchange), ElderServe - Special Needs, AETNA - Student Health, MVP Health Care - Child/Family Health Plus, Healthfirst - Child/Family Health Plus, Empire Blue Cross - EPO, AETNA - NY Signature, Amida Care - Special Needs, AETNA - Medicare Managed Care, Healthfirst - Medicare Managed Care, VNSNY CHOICE - SelectHealth, VNSNY CHOICE - Medicare Managed Care, MVP Health Care - Essential Plan, World Trade Center Health Plan - World Trade Center Health Plan, Medicare - Traditional Medicare, VNSNY CHOICE - Special Needs and MVP Health Care - HMO.
According to our sources, Dr. Igor Matushansky, MD PHD accepts the following insurance providers:
Dr. Igor Matushansky, MD PHD does not have any reviews yet, be the first to leave a review of Dr. Igor Matushansky, MD PHD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Igor Matushansky, MD PHD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Takeda Pharmaceuticals U.S.A., Inc. |
$111
$111 |
|---|---|
| Amgen Inc. |
$24
$24 |
| Food and Beverage | $135 |
|---|
Dr. Matushansky is a Professor of Medicine and the Director of the Sarcoma, Melanoma & Rare Tumor Medical Oncology Service at the Columbia University Medical Center. For over 20 years, Dr. Matushansky’s clinical practice has focused exclusively on the treatment and care of patients with sarcomas (i.e., cancers of musculoskeletal origins) and/or sarcoma related diseases. From novel patient specific approaches using standard of care options to active involvement in ongoing translational research and Phase 1-3 clinical trials Dr. Matushansky continues to make significant contributions to advancing the scope of therapeutic options available to sarcoma patients. Dr. Matushansky earned a BA degree from Columbia College, Columbia University and MD & PhD degrees from Albert Einstein College of Medicine. He performed his internal medicine residency at New York Presbyterian Hospital/Weill Cornell Medical Center and then completed a fellowship in Medical Oncology, as well as a post-doctoral research fellowship in Cancer Biology at Memorial Sloan Kettering Cancer Center.